Table of Contents
From The Editor
- Clinical outcomes in diabetes: It’s not just the glucose (and it’s not so simple)
As we dig deeper into the reduction in cardiovascular deaths seen with some newer drugs, several questions arise.
The Clinical Picture
- Diabetic dyslipidemia with eruptive xanthoma
Off medications for 1 year, her triglyceride level was 10,250 mg/dL, hemoglobin A1c 12.4%.
- Pseudo-Ludwig angina
A woman on heparin developed a hematoma on the floor of her mouth that threatened to block her airway.
- Mediastinal granuloma due to histoplasmosis in a patient on infliximab
Immunosuppressive drugs can predispose to invasive fungal infection.
1-Minute Consult
- Are daily chest radiographs and arterial blood gas tests required in ICU patients on mechanical ventilation?
Although routine testing is common, it has low diagnostic yield and is unlikely to alter patient management.
Symptoms to Diagnosis
- A young man with acute chest pain
A young man presents with severe, pressure-like, midsternal, nonradiating pain, rated 10 on a scale of 10.
Current Drug Therapy
- Diabetes management: Beyond hemoglobin A1c
Other factors include cardiovascular benefit, weight control, hypoglycemia risk, and cost.
- ACE inhibitors and ARBs: Managing potassium and renal function
Concern about hyperkalemia and a decline in renal function has led to underuse of these drugs.
Editorial
- ACE inhibitor and ARB therapy: Practical recommendations
Inhibitors of the renin-angiotensin-aldosterone system are cornerstones of therapy of cardiovascular disease.
Review
Hemorrhoids: A range of treatmentsEach patient is unique, and with the range of options available, treatment can be individualized.
- Disparities in cardiovascular care: Past, present, and solutions
Cardiovascular disease makes no distinction in race, sex, age, or socioeconomic status, and neither should clinicians.
